Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
Abstract: Immune checkpoint inhibitors, including cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) inhibitors, represent an effective treatment modality for multiple malignancies. Despite the exciting clinical benefits, checkpoint inhibition is associated with a series of...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2018
|
| Assuntos: | |
| Texto completo: | http://www.repositorio.ufc.br/handle/riufc/29143 |
| País: | Brasil |
| Oai: | oai:www.repositorio.ufc.br:riufc/29143 |